Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Monique Nijhuis

Showing results (11-20 of 106) with videos related to

Pageof 11
Sort By:
Antiviral Research|April 10, 2007
Insertions in the beta3-beta4 loop of reverse transcriptase of human immunodeficiency virus type 1 and their mechanism of action, influence on drug susceptibility and viral replication capacityDirk Eggink, Marleen C D G Huigen, Charles A B Boucher, et al.
Journal of the International AIDS Society|November 15, 2014
Use of dolutegravir in two INI-experienced patients with multiclass resistance resulted in excellent virological and immunological responsesLaura Marije Hofstra, Monique Nijhuis, Tania Mudrikova, et al.
The Journal of Antimicrobial Chemotherapy|April 20, 2011
Evolutionary pathways of transmitted drug-resistant HIV-1Marieke Pingen, Monique Nijhuis, Johan A de Bruijn, et al.
Antiviral Therapy|February 17, 2007
HIV-1 transmission cluster with M41L 'singleton' mutation and decreased transmission of resistance in newly diagnosed Swedish homosexual menAnna Lindström, Anna Ohlis, Marleen Huigen, et al.
Analytical Biochemistry|April 12, 2015
Robust regression methods for real-time polymerase chain reactionWim Trypsteen, Jan De Neve, Kobus Bosman, et al.
AIDS (London, England)|December 31, 2008
HIV monotherapy with ritonavir-boosted protease inhibitors: a systematic reviewWouter F W Bierman, Michiel A van Agtmael, Monique Nijhuis, et al.
Plos One|June 17, 2024
Periodontal inflammation as a potential driver of HIV low level viremiaArjen J Stam, Hester Groenewegen, Arjan Vissink, et al.
Retrovirology|August 26, 2011
HIV-1 protease inhibitor mutations affect the development of HIV-1 resistance to the maturation inhibitor bevirimatAxel Fun, Noortje M van Maarseveen, Jana Pokorná, et al.
Journal of Clinical Microbiology|October 2, 2002
Rapid and sensitive routine detection of all members of the genus enterovirus in different clinical specimens by real-time PCRMonique Nijhuis, Noortje van Maarseveen, Rob Schuurman, et al.
Plos One|October 30, 2014
Residual viremia is preceding viral blips and persistent low-level viremia in treated HIV-1 patientsLaura Marije Hofstra, Tania Mudrikova, Arjen J Stam, et al.
Pageof 11

Showing results (11-20 of 106) with videos related to

Sort By:
Pageof 11
Antiviral Research|April 10, 2007
Insertions in the beta3-beta4 loop of reverse transcriptase of human immunodeficiency virus type 1 and their mechanism of action, influence on drug susceptibility and viral replication capacityDirk Eggink, Marleen C D G Huigen, Charles A B Boucher, et al.
Journal of the International AIDS Society|November 15, 2014
Use of dolutegravir in two INI-experienced patients with multiclass resistance resulted in excellent virological and immunological responsesLaura Marije Hofstra, Monique Nijhuis, Tania Mudrikova, et al.
The Journal of Antimicrobial Chemotherapy|April 20, 2011
Evolutionary pathways of transmitted drug-resistant HIV-1Marieke Pingen, Monique Nijhuis, Johan A de Bruijn, et al.
Antiviral Therapy|February 17, 2007
HIV-1 transmission cluster with M41L 'singleton' mutation and decreased transmission of resistance in newly diagnosed Swedish homosexual menAnna Lindström, Anna Ohlis, Marleen Huigen, et al.
Analytical Biochemistry|April 12, 2015
Robust regression methods for real-time polymerase chain reactionWim Trypsteen, Jan De Neve, Kobus Bosman, et al.
AIDS (London, England)|December 31, 2008
HIV monotherapy with ritonavir-boosted protease inhibitors: a systematic reviewWouter F W Bierman, Michiel A van Agtmael, Monique Nijhuis, et al.
Plos One|June 17, 2024
Periodontal inflammation as a potential driver of HIV low level viremiaArjen J Stam, Hester Groenewegen, Arjan Vissink, et al.
Retrovirology|August 26, 2011
HIV-1 protease inhibitor mutations affect the development of HIV-1 resistance to the maturation inhibitor bevirimatAxel Fun, Noortje M van Maarseveen, Jana Pokorná, et al.
Journal of Clinical Microbiology|October 2, 2002
Rapid and sensitive routine detection of all members of the genus enterovirus in different clinical specimens by real-time PCRMonique Nijhuis, Noortje van Maarseveen, Rob Schuurman, et al.
Plos One|October 30, 2014
Residual viremia is preceding viral blips and persistent low-level viremia in treated HIV-1 patientsLaura Marije Hofstra, Tania Mudrikova, Arjen J Stam, et al.
Pageof 11